The healthcare giant is dealing with the fast-approaching patent cliff for its most important product, cancer medicine ...

Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...

Merck plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on ...

Merck said on Tuesday it would not ship its HPV vaccine Gardasil in China until at least the middle of this year due to weak ...

Merck topped Wall Street's fourth-quarter expectations Tuesday, but Merck stock could take a hit on lighter-than-expected 2025 sales guidance.

Financial writer recommends Merck & Co., Inc. as a strong healthcare stock despite recent challenges, citing strong potential ...

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the Phase 3 HYPERION study evaluating ...

BusinessWire India Accra [Ghana] Mumbai Maharashtra [India] January 31 Senator Dr Rasha Kelej CEO of Merck Foundation and ...

As the nation kicks off Black History Month, a look into the industry shows there is a significant lack of Black leaders.

The healthcare pioneer shares insights on transformative diagnostics where precision medicine meets women’s health innovation ...

India], January 4: Merck Foundation, the philanthropic arm of Merck KGaA Germany, marks ‘World Cancer Day 2025’ together with ...